J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
The Journal of New Drugs, 1965; 5:90-93
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turns, D.
Right arrow Articles by Teller, D. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Turns, D.
Right arrow Articles by Teller, D. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Preliminary Clinical Study of Propericiazine

Danielle Turns M.D.1, Herman C. B. Denber M.D., M.S.1, and David N. Teller Ph.D.1

1 Research Division, Manhattan State Hospital, Ward's Island, New York 35, N. Y.

Propericiazine (SK&F 20,716) was effective in the treatment of severe be havioral disorders in nine of 17 patients who were previously refractory to other medication. The dose range was 75 to 600 mg. daily. Side reactions were mild and offered no difficulty in management. Controlled trials would now appear warranted.

Note:

This study was supported in part by Grant MH-05093-03, Department of Health, Education, and Welfare, National Institutes of Health, Bethesda, Md.

The authors acknowledge with thanks the assistance rendered by Dr. John E. Overall, Director, Research Computation Center, The University of Texas-Medical Branch, Galveston, Texas.

Propericiazine was furnished through the kind co-operation of Mr. Donald B. Cheetham, Jr., Research Associate, Smith Kline & French Laboratories, Philadelphia, Pa.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1965 by the American College of Clinical Pharmacology